Restricted accessResearch articleFirst published online 2019-03
Asthma Guidelines Priority Topics: Intermittent Inhaled Corticosteroid Therapy and Inhaled Corticosteroids with Long Acting Beta-Agonists as Reliever Therapy
The National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of Asthma will update the guidelines on 6 topic areas. This review summarizes the findings for the charge to assess effectiveness of intermittent inhaled corticosteroid therapy with and without long-acting beta-agonist therapy in children 0 to 4 years of age, and children and adults 5 years and older. The complete report can be found on the Agency for Healthcare Research and Quality website.
Get full access to this article
View all access options for this article.
References
1.
BlakeKV, RaissyH. Asthma Guidelines from the National Asthma Education and Prevention Program: Where Are We Now?. Pediatr Allergy Immunol Pulmonol, 2018; 31:37–39.
2.
BlakeKV, RaissyHH. Asthma Guidelines Priority Topic: Long-Acting Anti-Muscarinic Agents in Asthma Management as Add-On to Inhaled Corticosteroids. Pediatr Allergy Immunol Pulmonol, 2018; 31:199–203.
3.
O'ByrnePM, FitzGeraldJM, BatemanED, et al.Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med, 2018; 378:1865–1876.
4.
BatemanED, ReddelHK, O'ByrnePM, et al.As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med, 2018; 378:1877–1887.
5.
SuminoK, BacharierLB, TaylorJ, et al.The real-world effectiveness of symptom-based, intermittent inhaled corticosteroid adjustment in African American Children with Asthma. A35 asthma clinical studies II. Am Thorac Soc, 2018; 197:A1426.
